Motorola Completes Development of Low-density Clinical Microarrays | GenomeWeb

NEW YORK, Oct. 30 – Motorola announced Monday it has completed development of its eSensor low-density clinical microarray, and will begin manufacturing this instrument in the second quarter of next year.

The company’s Clinical Micro Sensors business unit is making the sensors to do DNA testing for health care, agriculture, and environmental monitoring, as previously reported in GenomeWeb.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: global genetic diversity map, and more.

The Nuffield Council on Bioethics identifies ethical questions to explore surrounding genome editing.

In a blog post, Brigham and Women's Hospital's Robert Green discusses "predispositional personal genome sequencing."

Stat News reports that there's muted opposition to the Kuwaiti DNA database law.